CDC: Flu activity remains elevated
ATLANTA — According to last week’s FluView report, released Friday, influenza activity remains elevated nationally. Flu activity is likely to continue for several more weeks, the Centers for Disease Control and Prevention concluded.
For the week of Jan. 26 through Feb. 1, the national proportion of people seeing their healthcare provider for influenza-like illness decreased slightly for the fifth week, but remains above the national baseline. All 10 regions continue to report ILI activity above their region-specific baseline level.
Seven states experienced high ILI activity (Alabama, Arkansas, Kansas, Louisiana, Oklahoma, Texas and Virginia); a decrease from the 10 states with high ILI activity last week. Twelve states experienced moderate ILI activity.
HDMA promotes several staff members
ARLINGTON, Va. — The Healthcare Distribution Management Association on Saturday announced the promotion of six staff members:
- Perry Fri, from SVP to EVP industry relations, membership and education;
- Patrick Kelly from SVP to EVP government affairs;
- Liz Gallenagh, from VP government affairs and general counsel, to SVP government affairs and general counsel;
- John Parker from VP to SVP communications;
- Linda Caporaletti-Hoyt from senior director to VP human resources; and
- John Howells from senior director to VP industry relations.
“The promotions reflect the significant and successful contributions of these individuals to effectively represent the needs of our organization and its members,” stated HDMA president and CEO John Gray. “Thanks to their hard work, and that of their colleagues, HDMA was able to deliver high-quality results for the pharmaceutical distribution industry on many fronts, including the recent enactment of the transformational federal traceability legislation.”
ECG monitor AliveCor granted OTC status
SAN FRANCISCO — AliveCor on Monday announced that the Food and Drug Administration has granted the company over-the-counter clearance for the AliveCor Heart Monitor, a single-channel ECG (electrocardiogram) recorder, previously available by prescription only. The device is available now for pre-order purchase with shipments beginning in March.
The AliveCor Heart Monitor provides people with suspected or diagnosed heart conditions, and those at risk of heart conditions, the ability to track their heart health anytime, anywhere, at an affordable cost. Health professionals and patients have reported using the device to detect, monitor and analyze irregular heart rhythms.
“Over-the-counter access to mobile health devices has the potential to change the way consumers manage their overall health, facilitate preventative medical care and save both patients and healthcare professionals time,” stated Euan Thomson, president and CEO AliveCor. “We are pleased to now provide easier access to our innovative Heart Monitor and with the help of healthcare professionals provide timely analysis of data to all users.”
The AliveCor Heart Monitor’s medical grade ECG recordings can be shared directly with a user’s physician, or sent to a U.S. board-certified cardiologist or a U.S. based cardiac technician through AliveInsights, an analysis service that offers expert review of ECGs directly through the free AliveECG app. Recordings are then reviewed and analyzed providing users with a more complete picture of their current heart health.
The AliveCor Heart Monitor is the only FDA-cleared mobile ECG recorder that supports both iPhone and Android smartphones. It records, displays, stores and transfers single-channel ECG rhythms wirelessly, using the free AliveECG app. With secure storage in the cloud, users can access their data confidentially anytime, anywhere, and can grant access to their physician.
The AliveCor Heart Monitor can now be purchased at www.alivecor.com at a cost of $199.